Cargando…

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol

Dedicated breast positron emission tomography (dbPET) is an emerging technology with high sensitivity and spatial resolution that enables detection of sub-centimeter lesions and depiction of intratumoral heterogeneity. In this study, we report our initial experience with dbPET using [F-18]fluoroestr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Ella F., Ray, Kimberly M., Li, Wen, Chien, Amy J., Mukhtar, Rita A., Esserman, Laura J., Franc, Benjamin L., Seo, Youngho, Pampaloni, Miguel H., Joe, Bonnie N., Hylton, Nola M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467896/ https://www.ncbi.nlm.nih.gov/pubmed/31016232 http://dx.doi.org/10.1038/s41523-019-0107-9

Ejemplares similares

Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
por: Hathi, Deep K., et al.
Publicado: (2020)

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
por: Jones, Ella F., et al.
Publicado: (2020)

Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
por: Ivanidze, Jana, et al.
Publicado: (2021)

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
por: Huang, Shih-ying, et al.
Publicado: (2018)

Diagnostic and Prognostic Role of (18)F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
por: Fiz, Francesco, et al.
Publicado: (2022)

The Preliminary Study of 16α-[18F]fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients
por: Sun, Yifei, et al.
Publicado: (2015)

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
por: Liu, Cheng, et al.
Publicado: (2022)

18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis
por: Matushita, Cristina S., et al.
Publicado: (2023)

Synthesis of Clinical-Grade [(18)F]-Fluoroestradiol as a Surrogate PET Biomarker for the Evaluation of Estrogen Receptor-Targeting Therapeutic Drug
por: Dixit, Manish, et al.
Publicado: (2013)

Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
por: Li, Wen, et al.
Publicado: (2016)

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
por: van Kruchten, Michel, et al.
Publicado: (2015)

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial
por: Onishi, Natsuko, et al.
Publicado: (2020)

Clinical practice guideline for dedicated breast PET
por: Hosono, Makoto, et al.
Publicado: (2014)

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer
por: Li, Wen, et al.
Publicado: (2020)

Comparison of diagnostic sensitivity of [(18)F]fluoroestradiol and [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
por: Chae, Sun Young, et al.
Publicado: (2020)

Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes
por: Lo, Wei-Ching, et al.
Publicado: (2016)

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET
por: Koolen, B. B., et al.
Publicado: (2012)

Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer? ----A Pilot Study
por: Yang, Zhongyi, et al.
Publicado: (2013)

Quick Automatic Synthesis of Solvent-Free 16α-[(18)F] Fluoroestradiol: Comparison of Kryptofix 222 and Tetrabutylammonium Bicarbonate
por: Jiang, Xiao, et al.
Publicado: (2020)

Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis
por: Mo, Jin A
Publicado: (2021)

ClearPEM: prototype PET device dedicated to breast imaging
por: Joao Varela
Publicado: (2009)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
por: Mukhtar, Rita A., et al.
Publicado: (2013)

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

A Proposed Dedicated Breast PET Lexicon: Standardization of Description and Reporting of Radiotracer Uptake in the Breast
por: Miyake, Kanae K., et al.
Publicado: (2021)

Can (18)F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with (18)F-Fluorodeoxyglucose Positron Emission Tomography?
por: Gupta, Manoj, et al.
Publicado: (2017)

Clear-PEM: A PET imaging system dedicated to breast cancer diagnostics
por: Abreu, M C, et al.
Publicado: (2007)

MLTI-18. PRECISION IMAGING OF METASTATIC AND PRIMARY BRAIN TUMORS AFTER RADIATION WITH (18)F-FDOPA PET-MRI IS FEASIBLE AND COST EFFECT
por: Aboian, Mariam, et al.
Publicado: (2019)

Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
por: de Mooij, Cornelis M., et al.
Publicado: (2023)

Imaging Bone–Cartilage Interactions in Osteoarthritis Using [(18)F]-NaF PET-MRI
por: Savic, Dragana, et al.
Publicado: (2016)

Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT in Patients with Breast Cancer—A Proof-of-Concept Study
por: Malhotra, Anmol, et al.
Publicado: (2020)

Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer
por: Le, Nu N., et al.
Publicado: (2022)

Improved visualization of breast tissue on a dedicated breast PET system through ergonomic redesign of the imaging table
por: O’Connor, Michael K., et al.
Publicado: (2017)

Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy
por: Nguyen, Alex Anh-Tu, et al.
Publicado: (2020)

A dedicated paediatric [(18)F]FDG PET/CT dosage regimen
por: Cox, Christina P. W., et al.
Publicado: (2021)

Beneficial Effects of Melatonin on Apolipoprotein-E Knockout Mice by Morphological and (18)F-FDG PET/CT Assessments
por: Nardo, Lorenzo, et al.
Publicado: (2020)

Image artifacts from MR-based attenuation correction in dedicated PET/MR breast coil for PET/MR mammography
por: Cho, Ihnho, et al.
Publicado: (2015)

A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([(18)F]GE-180) PET/MRI
por: Kim, Sally Ji Who, et al.
Publicado: (2023)

Is (18)F-FDG PET/CT Beneficial for Newly Diagnosed Breast Cancer Patients With Low Proportion of ER Expression?
por: Liu, Jiachen, et al.
Publicado: (2021)

Texture Analysis in the Diagnosis of Primary Breast Cancer: Comparison of High-Resolution Dedicated Breast Positron Emission Tomography (dbPET) and Whole-Body PET/CT
por: Satoh, Yoko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8o48fr1u3b1frngqajljrc7d9u